Karin J. Stebbins

1.0k total citations
24 papers, 660 citations indexed

About

Karin J. Stebbins is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Karin J. Stebbins has authored 24 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Physiology and 4 papers in Oncology. Recurrent topics in Karin J. Stebbins's work include Asthma and respiratory diseases (7 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Karin J. Stebbins is often cited by papers focused on Asthma and respiratory diseases (7 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Karin J. Stebbins collaborates with scholars based in United States, Canada and Belgium. Karin J. Stebbins's co-authors include Daniel S. Lorrain, Ari Green, Jonah R. Chan, Peppi Prasit, Kelsey A. Rankin, Feng Mei, Klaus Lehmann‐Horn, Scott S. Zamvil, Yun‐An Shen and H.‐Christian von Büdingen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Karin J. Stebbins

23 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin J. Stebbins United States	11	241	161	157	124	117	24	660
Shireen Hossain Canada	12	191 0.8×	97 0.6×	95 0.6×	88 0.7×	56 0.5×	12	518
Yoko Sakurai Japan	14	367 1.5×	118 0.7×	105 0.7×	67 0.5×	80 0.7×	24	676
Michael Hedvat United States	10	465 1.9×	41 0.3×	64 0.4×	120 1.0×	62 0.5×	16	953
Hyesook Yoon United States	19	272 1.1×	130 0.8×	82 0.5×	69 0.6×	143 1.2×	30	908
Núria Llecha Spain	13	561 2.3×	65 0.4×	66 0.4×	85 0.7×	55 0.5×	15	888
Kara Pekarek United States	5	211 0.9×	155 1.0×	40 0.3×	157 1.3×	158 1.4×	5	542
Sanaa Nabha United States	16	388 1.6×	65 0.4×	59 0.4×	48 0.4×	55 0.5×	35	886
Wei‐Na Jin China	17	345 1.4×	97 0.6×	85 0.5×	282 2.3×	445 3.8×	31	983
Eric Koncina Luxembourg	12	608 2.5×	74 0.5×	79 0.5×	130 1.0×	183 1.6×	17	1.1k
Maria Podbielska Poland	16	331 1.4×	64 0.4×	77 0.5×	184 1.5×	80 0.7×	20	599

Countries citing papers authored by Karin J. Stebbins

Since Specialization

Citations

This map shows the geographic impact of Karin J. Stebbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin J. Stebbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin J. Stebbins more than expected).

Fields of papers citing papers by Karin J. Stebbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin J. Stebbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin J. Stebbins. The network helps show where Karin J. Stebbins may publish in the future.

Co-authorship network of co-authors of Karin J. Stebbins

This figure shows the co-authorship network connecting the top 25 collaborators of Karin J. Stebbins. A scholar is included among the top collaborators of Karin J. Stebbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin J. Stebbins. Karin J. Stebbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poon, Michael M., Karin J. Stebbins, Christopher Baccei, et al.. (2024). Discovery of a brain penetrant small molecule antagonist targeting LPA1 receptors to reduce neuroinflammation and promote remyelination in multiple sclerosis. Scientific Reports. 14(1). 10573–10573. 3 indexed citations

Stebbins, Karin J., Jeffrey Roppe, Christopher Baccei, et al.. (2024). Targeting the muscarinic M1 receptor with a selective, brain-penetrant antagonist to promote remyelination in multiple sclerosis. Proceedings of the National Academy of Sciences. 121(32). e2407974121–e2407974121. 14 indexed citations

Schrader, Thomas O., Didier Bagnol, Christopher Baccei, et al.. (2024). Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy. ACS Chemical Neuroscience. 15(3). 685–698. 3 indexed citations

Cordano, Christian, Garrett Timmons, Hao Yiu, et al.. (2022). Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy. Brain. 145(11). 3943–3952. 41 indexed citations

Jacintho, Jason, Christopher Baccei, Austin Chen, et al.. (2018). Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies. Bioorganic & Medicinal Chemistry Letters. 29(3). 503–508. 7 indexed citations

Stebbins, Karin J., Lucia Correa, Davorka Messmer, et al.. (2017). In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist. European Journal of Pharmacology. 809. 130–140. 25 indexed citations

Mei, Feng, Klaus Lehmann‐Horn, Yun‐An Shen, et al.. (2016). Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery. eLife. 5. 226 indexed citations

Messmer, Davorka, Karin J. Stebbins, Nicholas Stock, et al.. (2015). A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo. Molecular Medicine. 21(1). 410–419. 36 indexed citations

Baccei, Christopher, Richard A. Bundey, Austin Chen, et al.. (2014). Identification of the first potent, selective and bioavailable PPARα antagonist. Bioorganic & Medicinal Chemistry Letters. 24(10). 2267–2272. 9 indexed citations

10.

Bain, Gretchen, Daniel S. Lorrain, Karin J. Stebbins, et al.. (2011). Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 338(1). 290–301. 20 indexed citations

11.

Stebbins, Karin J., Alla Musiyenko, Sailen Barik, et al.. (2011). DP2 (CRTh2) Antagonism Reduces Ocular Inflammation Induced by Allergen Challenge and Respiratory Syncytial Virus. International Archives of Allergy and Immunology. 157(3). 259–268. 6 indexed citations

12.

Stebbins, Karin J., Jilly F. Evans, & Daniel S. Lorrain. (2010). DP2 Receptor Antagonists: Novel Therapeutic Target for COPD. 2(3). 89–96. 4 indexed citations

13.

Stock, Nicholas, Deborah L. Volkots, Karin J. Stebbins, et al.. (2010). Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 21(3). 1036–1040. 9 indexed citations

14.

Stebbins, Karin J., Lucia Correa, Brian A. Stearns, et al.. (2010). Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation. European Journal of Pharmacology. 638(1-3). 142–149. 42 indexed citations

15.

Dulos, John, Karin J. Stebbins, Jörg Hamann, et al.. (2009). Therapeutic Antibody Targeting of CD97 in Experimental Arthritis: the Role of Antigen Expression, Shedding, and Internalization on the Pharmacokinetics of Anti-CD97 Monoclonal Antibody 1B2. The Journal of Immunology. 183(6). 4127–4134. 30 indexed citations

16.

Stebbins, Karin J., Christopher Baccei, Heather Coate, et al.. (2009). Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung. Journal of Pharmacology and Experimental Therapeutics. 332(3). 764–775. 40 indexed citations

17.

Doukas, John, Karin J. Stebbins, Luis Dellamary, et al.. (2008). Aerosolized Phosphoinositide 3-Kinase γ/δ Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease. Journal of Pharmacology and Experimental Therapeutics. 328(3). 758–765. 86 indexed citations

18.

Burton, Maggi, Philippe Collart, Tanmoy Ganguly, et al.. (2007). Discovery of new C3aR ligands. Part 1: Arginine derivatives. Bioorganic & Medicinal Chemistry Letters. 17(12). 3258–3261. 10 indexed citations

19.

Provins, Laurent, et al.. (2007). Dual M3 antagonists-PDE4 inhibitors. Part 2: Synthesis and SAR of 3-substituted azetidinyl derivatives. Bioorganic & Medicinal Chemistry Letters. 17(11). 3077–3080. 36 indexed citations

20.

Stebbins, Karin J., et al.. (2003). Effect of olvanil on the afferent and efferent function of capsaicin-sensitive C-fibers in guinea pig airways. European Journal of Pharmacology. 471(3). 205–211. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact